Free Trial

Invesco Biotechnology & Genome ETF (PBE) Institutional Ownership

Invesco Biotechnology & Genome ETF logo
$96.72 +1.78 (+1.87%)
Closing price 04:10 PM Eastern
Extended Trading
$96.67 -0.05 (-0.05%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Number of
Institutional Buyers
(last 12 months)
39
Total
Institutional Inflows
(last 12 months)
$43.18M
Number of
Institutional Sellers
(last 12 months)
24
Total
Institutional Outflows
(last 12 months)
$17.58M
Get PBE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Invesco Biotechnology & Genome ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PBE Institutional Buying and Selling by Quarter

Invesco Biotechnology & Genome ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/14/2026MinichMacGregor Wealth Management LLC3,819$372K0.1%N/A0.088%
10/9/2026Allen Mooney & Barnes Investment Advisors LLC2,100$204K0.0%N/A0.048%
10/8/2026YHB Investment Advisors Inc.22,296$2.17M0.1%N/A0.510%
9/23/2026Envestnet Asset Management Inc.22,250$2.00M0.0%+4.2%0.510%
9/9/2026Archford Capital Strategies LLC6,252$560K0.1%+6.7%0.198%
9/9/2026Integrated Wealth Concepts LLC942$84K0.0%N/A0.030%
9/9/2026NewEdge Advisors LLC648$58K0.0%-40.6%0.021%
9/2/2026Citadel Advisors LLC4,999$448K0.0%-41.7%0.159%
8/22/2026Compass Financial Management LLC300$27K0.0%N/A0.010%
8/12/2026Compass Financial Management LLC300$27K0.0%N/A0.010%
7/7/2026Dynamic Advisor Solutions LLC5,398$484K0.0%N/A0.174%
5/19/2026Bank of America Corp DE59,290$4.70M0.0%-4.0%1.906%
5/18/2026Royal Bank of Canada59,329$4.70M0.0%+25.9%1.908%
5/13/2026Cetera Investment Advisers23,139$1.83M0.0%+2.0%0.744%
5/1/2026Fifth Third Bancorp378$30K0.0%N/A0.012%
4/30/2026Kestra Advisory Services LLC6,280$497K0.0%+7.0%0.201%
4/22/2026Janney Montgomery Scott LLC3,830$303K0.0%-9.0%0.122%
3/17/2026Rockefeller Capital Management L.P.10,666$876K0.0%+6.7%0.332%
2/18/2026NewEdge Advisors LLC1,043$86K0.0%+18.1%0.032%
2/18/2026VestGen Advisors LLC2,610$214K0.0%-44.3%0.081%
2/17/2026Cetera Investment Advisers22,675$1.86M0.0%+3.1%0.706%
2/17/2026GeoWealth Management LLC2,010$165K0.0%-23.3%0.063%
2/17/2026Osaic Holdings Inc.8,963$736K0.0%-4.8%0.279%
2/17/2026Royal Bank of Canada47,114$3.87M0.0%-0.6%1.468%
2/16/2026MML Investors Services LLC2,497$205K0.0%N/A0.078%
2/13/2026CreativeOne Wealth LLC11,384$935K0.0%-4.5%0.355%
2/13/2026Stifel Financial Corp6,409$526K0.0%-6.3%0.200%
2/13/2026Wells Fargo & Company MN46,856$3.85M0.0%-0.7%1.460%
2/13/2026Gerber Kawasaki Wealth & Investment Management42,909$3.53M0.1%-7.0%1.337%
2/12/2026Commonwealth Equity Services LLC21,913$1.80M0.0%-12.4%0.683%
2/12/2026Steward Partners Investment Advisory LLC1,250$103K0.0%+51.5%0.039%
2/12/2026Moneta Group Investment Advisors LLC2,718$223K0.0%N/A0.085%
2/12/2026Colonial Trust Advisors304$25K0.0%N/A0.009%
2/11/2026Janney Montgomery Scott LLC4,208$346K0.0%-3.1%0.131%
2/11/2026LPL Financial LLC97,304$7.99M0.0%+5.0%3.031%
2/11/2026Wharton Business Group LLC2,739$225K0.0%N/A0.085%
2/10/2026One Capital Management LLC9,687$796K0.0%-5.0%0.302%
2/10/2026Northwestern Mutual Wealth Management Co.2,335$192K0.0%-36.9%0.073%
2/9/2026Harbour Investments Inc.519$43K0.0%-25.4%0.016%
2/5/2026Northwestern Mutual Wealth Management Co.342,971$28.18M0.0%+9,169.5%10.684%
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel

Click here to see the document and learn protective steps
2/5/2026Western Wealth Management LLC2,731$224K0.0%N/A0.085%
2/5/2026Pacific Sun Financial Corp4,847$398K0.2%-6.5%0.151%
2/3/2026RFG Advisory LLC8,455$695K0.0%+6.6%0.263%
1/29/2026Comerica Bank378$31K0.0%+86.2%0.012%
1/29/2026UBS Group AG67,361$5.53M0.0%-6.5%2.098%
1/27/2026Q3 Asset Management17,429$1.43M0.3%N/A0.543%
1/27/2026Institute for Wealth Management LLC.20,268$1.67M0.2%-2.4%0.631%
1/26/2026Massachusetts Wealth Management17,919$1.47M0.7%-2.3%0.560%
1/22/2026Newman Dignan & Sheerar Inc.10,070$827K0.2%+3.0%0.316%
1/20/2026Stratos Wealth Partners LTD.3,165$260K0.0%N/A0.099%
1/9/2026BOS Asset Management LLC2,439$200K0.1%N/A0.077%
1/8/2026Wealth Enhancement Advisory Services LLC4,562$383K0.0%-4.0%0.144%
1/8/2026Signet Financial Management LLC3,299$271K0.0%-10.5%0.104%
1/7/2026Harbor Investment Advisory LLC1,275$105K0.0%+750.0%0.040%
11/18/2025Advisory Services Network LLC1,173$82K0.0%N/A0.037%
11/17/2025NewEdge Advisors LLC883$62K0.0%+63.2%0.028%
11/17/2025United Capital Financial Advisors LLC85,095$5.95M0.0%N/A2.719%
11/17/2025Citadel Advisors LLC2,953$206K0.0%N/A0.094%
11/17/2025Bank of America Corp DE59,918$4.19M0.0%+2.5%1.914%
11/14/2025Raymond James Financial Inc.8,078$564K0.0%+1.8%0.258%
11/14/2025One Capital Management LLC10,200$713K0.0%-20.5%0.326%
11/13/2025Pacific Sun Financial Corp5,185$362K0.2%-7.7%0.166%
11/13/2025GeoWealth Management LLC2,621$183K0.0%-7.5%0.084%
11/13/2025UBS Group AG72,025$5.03M0.0%-5.2%2.301%
11/13/2025Gerber Kawasaki Wealth & Investment Management46,137$3.22M0.1%-81.8%1.474%
11/13/2025CreativeOne Wealth LLC11,916$833K0.0%-22.3%0.381%
11/13/2025Blair William & Co. IL1,000$70K0.0%+150.0%0.032%
11/10/2025Abbot Financial Management Inc.12,425$868K0.4%-2.4%0.397%
11/7/2025Signet Financial Management LLC3,687$258K0.0%-15.3%0.118%
11/7/2025PNC Financial Services Group Inc.574$40K0.0%+74.5%0.018%
11/6/2025RFG Advisory LLC7,934$554K0.0%+69.4%0.253%
11/5/2025Envestnet Asset Management Inc.19,723$1.38M0.0%+7.7%0.630%
10/31/2025Investment House LLC8,580$599K0.0%+14.7%0.274%
10/30/2025Joel Isaacson & Co. LLC3,025$211K0.0%N/A0.097%
10/17/2025Archford Capital Strategies LLC3,189$223K0.0%-13.1%0.102%
10/17/2025Sowell Financial Services LLC2,980$208K0.0%N/A0.095%
10/9/2025Newman Dignan & Sheerar Inc.9,772$683K0.1%-6.7%0.311%
9/4/2025Osaic Holdings Inc.9,441$605K0.0%+9.9%0.274%
8/15/2025IHT Wealth Management LLC15,339$983K0.0%-1.4%0.445%
8/15/2025Bank of America Corp DE58,465$3.75M0.0%-11.4%1.695%
8/15/2025Abbot Financial Management Inc.12,725$816K0.4%-3.6%0.369%
8/14/2025Raymond James Financial Inc.7,937$509K0.0%-12.7%0.230%
8/14/2025Investment House LLC7,480$479K0.0%-6.3%0.217%
8/14/2025Gerber Kawasaki Wealth & Investment Management254,172$16.29M0.6%+4.2%7.367%
8/13/2025VestGen Advisors LLC4,704$313K0.0%-6.9%0.136%
8/12/2025CreativeOne Wealth LLC15,333$983K0.0%-14.3%0.444%
8/12/2025JPMorgan Chase & Co.501$32K0.0%-93.6%0.015%
8/8/2025Cetera Investment Advisers20,398$1.31M0.0%-3.4%0.591%
8/8/2025Creative Planning3,223$207K0.0%-81.5%0.093%
8/7/2025Allworth Financial LP850$54K0.0%N/A0.025%
The Iran War Isn’t Chaos. It’s Strategy. (Ad)

Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.tc pixel

Uncover the hidden strategy behind the Iran war now
8/5/2025Hills Bank & Trust Co4,887$313K0.0%-6.3%0.142%
8/4/2025Creative Financial Designs Inc. ADV2,971$190K0.0%-32.8%0.086%
7/30/2025Pacific Sun Financial Corp5,618$360K0.2%-7.0%0.163%
7/28/2025RFG Advisory LLC4,684$300K0.0%N/A0.136%
7/28/2025Axxcess Wealth Management LLC4,725$303K0.0%-10.4%0.137%
7/23/2025Massachusetts Wealth Management18,394$1.18M0.7%+1.0%0.530%
7/18/2025Newman Dignan & Sheerar Inc.10,472$671K0.2%-3.7%0.302%
7/17/2025Janney Montgomery Scott LLC5,080$326K0.0%-6.3%0.146%
7/17/2025Archford Capital Strategies LLC3,669$235K0.0%-19.2%0.106%
7/16/2025Dakota Wealth Management4,901$314K0.0%-38.5%0.141%


PBE Institutional Ownership - Frequently Asked Questions

During the previous two years, 84 institutional investors and hedge funds held shares of Invesco Biotechnology & Genome ETF. The most heavily invested institutionals were LPL Financial LLC ($7.99M), United Capital Financial Advisors LLC ($5.95M), UBS Group AG ($5.53M), Royal Bank of Canada ($4.70M), Bank of America Corp DE ($4.70M), Wells Fargo & Company MN ($3.85M), and Gerber Kawasaki Wealth & Investment Management ($3.53M).Learn more on Invesco Biotechnology & Genome ETF's institutional investors.

Of the 61 institutional investors that purchased Invesco Biotechnology & Genome ETF's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Northwestern Mutual Wealth Management Co. ($340.22K), United Capital Financial Advisors LLC ($85.10K), Raymond James Financial Inc. ($37.90K), Gerber Kawasaki Wealth & Investment Management ($37.13K), Royal Bank of Canada ($25.98K), YHB Investment Advisors Inc. ($22.30K), and Q3 Asset Management ($17.43K).

Institutional investors have bought a total of 535,631 shares in the last 24 months. This purchase volume represents approximately $43.18M in transactions.

Of the 24 institutional investors that sold Invesco Biotechnology & Genome ETF's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Gerber Kawasaki Wealth & Investment Management ($211.26K), UBS Group AG ($8.62K), CreativeOne Wealth LLC ($3.95K), Citadel Advisors LLC ($3.57K), One Capital Management LLC ($3.14K), Commonwealth Equity Services LLC ($3.09K), and Bank of America Corp DE ($2.44K).

Institutional investors have sold a total of 246,690 shares in the last 24 months. This volume of shares sold represents approximately $17.58M in transactions.



Institutional ownership data for NYSEARCA:PBE is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 10/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners